Experiences investigation for COVID-19 vaccination in patients with epilepsy.
Epilepsia Open
; 2022 Oct 28.
Article
in English
| MEDLINE | ID: covidwho-2287544
ABSTRACT
OBJECTIVE:
This study aimed to investigate the safety of COVID-19 vaccination in patients with epilepsy (PWE) and their willingness to undergo vaccination.METHODS:
This was a survey study. A questionnaire was completed by patients of the outpatient clinic and hospital ward at The Third Xiangya Hospital in 2021. The survey included general, epilepsy-specific, and COVID-specific questions.RESULTS:
In total, 120 valid questionnaires were returned. Eighty-nine of 120 patients (74.2%) were not vaccinated, and 31 (25.8%) received the COVID-19 vaccine. Of the 31 vaccinated PWE, one (3.2%) had worsening of seizures and four (12.9%) had adverse reactions that were characteristic of the COVID-19 vaccine. The other 26 patients (83.9%) reported no adverse reactions, Moreover, there was no significant difference between the 18 PWE with well-controlled seizureand the 13 PWE with poorly-controlled seizure. Of the 89 unvaccinated PWE, 69.7% (62/89) were willing to receive the COVID-19 vaccine, 28.1% (25/89) were unsure, and 2.2% (2/89) declined to be vaccinated.SIGNIFICANCE:
Among PWE, few adverse reactions occurred following the COVID-19 vaccination. Most PWE were willing to receive the COVID-19 vaccine. COVID-19 vaccination is safe for PWE.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Experimental Studies
/
Observational study
/
Qualitative research
Topics:
Vaccines
Language:
English
Year:
2022
Document Type:
Article
Affiliation country:
Epi4.12667
Similar
MEDLINE
...
LILACS
LIS